Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
41,966,083
-
Total 13F shares
-
8,999,825
-
Share change
-
-368,029
-
Total reported value
-
$26,370,118
-
Put/Call ratio
-
0%
-
Price per share
-
$2.93
-
Number of holders
-
49
-
Value change
-
-$1,294,700
-
Number of buys
-
20
-
Number of sells
-
23
Institutional Holders of Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) as of Q4 2023
As of 31 Dec 2023,
Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,999,825 shares.
The largest 10 holders included
BlackRock Inc., TPG GP A, LLC, VANGUARD GROUP INC, TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, and Nuveen Asset Management, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.